CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 40,000 enrolled
Drug / intervention
Postoperative analgesiaother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05884021
NCT05884021N/ACompleted

Effectiveness of Pain Control and Adverse Reactions After Intravenous PCA in Chinese Population

Huazhong University of Science and Technology·observational·Posted Jun 1, 2023·Updated Jun 1, 2023

In Brief

An observational study evaluating Postoperative analgesia for Postoperative Pain, Acute. Completed, enrolled 40,000 participants.

Detailed Summary

Here, we retrospectively analyzed the proportion of intravenous patient controlled analgesia (PCA) used in a large tertiary hospital in central China, and then further analyzed the proportion of patients with postoperative pain after standardized pain treatment and the incidence of adverse effects. It aims to answer are: 1. The incidence of poor postoperative analgesia and adverse effects of patients with different types of surgery after standardized postoperative pain management of TJ-APS team; 2. It would provide reference for improving the quality of postoperative acute pain management. In addition, it supplements the Chinese data on the incidence of poor postoperative analgesia and adverse effects of patients under the APS standardized postoperative analgesia process.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
Countries--
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedJun 1, 2023
Enrollment StartJan 1, 2016
Primary CompletionDec 31, 2021
Study CompletionDec 31, 2022
TodayJul 2, 2026
Enrollment to primary: 6 yearsPosted 3.1 years ago

Interventions

Postoperative analgesiaother

In patients who used intravenous PCA after surgery